Update

Akanksha, biological scientist, Dennis, graduate student, and Hayley, BS student joined Zhang Lab. Welcome!

Our lab received $1.9 million grant from the National Institutes of Health’s National Institute of General Medical Sciences to study the role of myeloid cells – critical mediators of inflammation – in nanotherapeutic treatments of diseases like cancer, sepsis, and autoimmune disorders.

Graduate student Kevon Jolly received 76K training funds from NCI to develop tumor-homing mRNA nanoparticles

Graduate Student Kevon Jolly (first left in the photo) won the Best Oral Talk Award at UF Biomaterials Day. His talk is based on a shared project between him and Zijing (another graduate studnet who co-leads this project). Congratulations to both graduate students for making significant discoveries in RNA delivery!

Congratulations to Kai Rubach, undergraduate student in our lab, was selected to the University Scholar Program!

Our lab has been awarded pilot funding through the Sepsis & Critical Illness Research Center’s Biomedical Research Collective (BRC): Enhancing the Interdisciplinary Approach to Translational Scientific Inquiry- an RM1GM139690 Pilot Program.

Zhang lab members presented their research at the annual COP research showcase

https://scirc.med.ufl.edu/2023/05/04/congrats-dr-fan-zhang-ctsi-kl2-career-development-award/

Congratualtions to Zijing and Kevon for publishing their first review paper titled 'Myeloid cell-mediated drug delivery: From nanomedicine to cell therapy' in Advanced Drug Delivery Review!

Our collaborative project with Dr. Schmittgen's lab received funding support from NCI. This work focuses on developing microRNA-based therapeutics for pancreatic cancer treatment.